Joseph D Tariman1, Colleen Lemoine. Show Affiliations » 1. Multiple Myeloma Program, Department of Medicine, Division of Hematology/Oncology, Northwestern University Medical Faculty Foundation, Chicago, IL, USA. jtariman@nmff.org
Abstract
Entities: Chemical
Mesh： See more » Antineoplastic Agents/administration & dosageAntineoplastic Agents/adverse effectsAntineoplastic Agents/pharmacologyApoptosis/drug effectsBoronic Acids/administration & dosageBoronic Acids/adverse effectsBoronic Acids/pharmacologyBortezomibDrug InteractionsHalf-LifeHumansMultiple Myeloma/drug therapyNursing AssessmentPatient Education as TopicProtease Inhibitors/administration & dosageProtease Inhibitors/adverse effectsProtease Inhibitors/pharmacologyPyrazines/administration & dosagePyrazines/adverse effectsPyrazines/pharmacology
Substances： See more » Antineoplastic AgentsBoronic AcidsProtease InhibitorsPyrazinesBortezomib
Year: 2003 PMID： 14705489 DOI： 10.1188/03.CJON.687-689
Source DB: PubMed Journal: Clin J Oncol Nurs ISSN： 1092-1095 Impact factor: 1.027